By Kimberly Chin

Applied DNA Sciences Inc. said Friday it has submitted an emergency-use authorization request for its Covid-19 assay and at-home Covid-19 test.

The Linea 2.0 Assay is an RT-PCR assay that targets the E and N genes of SARS-CoV-2. The Linea Unsupervised At-Home Sample Collection Kit allows people to easily self-administer a nasal swab sample that can then be mailed directly to Applied DNA Clinical Labs LLC. Results typically return within 24 to 48 hours upon the sample's arrival, the company said.

The test is capable of detecting all known Covid-19 variants, the company said.

The company said the approval could open a path for it to expand its fully integrated Covid-19 testing platform nationally, particularly in enterprises and educational institutions. The testing platform provides Covid-19 diagnostic testing and other services.

Write to Kimberly Chin at kimberly.chin@wsj.com

(END) Dow Jones Newswires

January 21, 2022 10:52 ET (15:52 GMT)